Page last updated: 2024-10-25

chlorpropamide and Goiter

chlorpropamide has been researched along with Goiter in 1 studies

Chlorpropamide: A sulfonylurea hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. (From Martindale, The Extra Pharmacopoeia, 30th ed, p277)
chlorpropamide : An N-sulfonylurea that is urea in which a hydrogen attached to one of the nitrogens is substituted by 4-chlorobenzenesulfonyl group and a hydrogen attached to the other nitrogen is substituted by propyl group. Chlorpropamide is a hypoglycaemic agent used in the treatment of type 2 (non-insulin-dependent) diabetes mellitus not responding to dietary modification.

Goiter: Enlargement of the THYROID GLAND that may increase from about 20 grams to hundreds of grams in human adults. Goiter is observed in individuals with normal thyroid function (euthyroidism), thyroid deficiency (HYPOTHYROIDISM), or hormone overproduction (HYPERTHYROIDISM). Goiter may be congenital or acquired, sporadic or endemic (GOITER, ENDEMIC).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
LINQUETTE, M1
FOSSATI, P1
GASNAULT, JP1
RACADOT, A1

Other Studies

1 other study available for chlorpropamide and Goiter

ArticleYear
[THE INTRAVENOUS CHLORPROPAMIDE TEST. EARLY AND LATE RESPONSES].
    Le Diabete, 1964, Volume: 12

    Topics: Acromegaly; Blood Glucose; Chlorpropamide; Cushing Syndrome; Goiter; Graves Disease; Humans; Hypogly

1964